Development of chemoresistance is the main reason for failure of clinical management of multiple myeloma (MM), but the genetic and epigenetic aberrations that interact to confer such chemoresistance remains unknown. In the present study, we find that high steroid receptor coactivator-3 (SRC-3) expression is correlated with relapse/refractory and poor outcomes in MM patients treated with bortezomib (BTZ)-based regimens. Furthermore, in immortalized cell lines, high SRC-3 enhances resistance to proteasome inhibitor (PI)-induced apoptosis. Overexpressed histone methyltransferase NSD2 in patients bearing a t(4;14) translocation or in BTZ-resistant MM cells coordinates elevated SRC-3 by enhancing its liquid–liquid phase separation to supranormally modify histone H3 lysine 36 dimethylation (H3K36me2) modifications on promoters of anti-apoptotic genes. Targeting SRC-3 or interference of its interactions with NSD2 using a newly developed inhibitor, SI-2, sensitizes BTZ treatment and overcomes drug resistance both in vitro and in vivo. Taken together, our findings elucidate a previously unrecognized orchestration of SRC-3 and NSD2 in acquired drug resistance of MM and suggest that SI-2 may be efficacious for overcoming drug resistance in MM patients.

No abstract

No abstract

Organophosphate esters (OPEs) are high-production-volume chemicals used as flame retardants. Some western countries (e. g. America and European Union) have imposed restrictions on OPEs in baby products due to their similar persistent-organic-pollutants (POPs) properties. So far, there is no domestic or foreign standard for OPEs flame retardants in baby carriages. Ultrasonic extraction was used to extract three OPEs from baby carriages, and the extracts were purified by a florisil solid phase extraction (SPE) column, and finally detected by gas chromatography-mass spectrometry (GC-MS). The spiked recoveries of the three OPEs were in the range of 89.5% to 107.3%. The limits of detection (3S/N) were 0.01 mg/kg, and the limits of quantification (10S/N) were 0.1 mg/kg. This method could eliminate matrix effects and give accurate qualitative analytical results for the three OPE flame retardants in baby carriages. Thirty-seven samples were analyzed and the tris (2-chloro-1-methylethyl) phosphate (TCPP) detection rate was up to 81.1% with the mass concentration range of 1.0-15 312.8 mg/kg, and 32.4% of the samples exceeded the European Union directive (2014/79/EU) for TCPP (> 5 mg/kg), as well as tris (2-chloroethyl) phosphate (TCEP) and tris [2-chloro-1-(chloromethyl) ethyl] phosphate(TDCP) in two samples, which were in the range of 6.2-44.1 mg/kg. Thus, relatively high OPEs flame retardants risk was presented in baby carriages.

No abstract